Robert Weisman

1 month ago | bostonglobe.com | Robert Weisman

Chief operating officer Maggie O’Toole, who was employee No. 1 when LabCentral launched in 2013, will take over as CEO on May 1. LabCentral’s cofounder Joannes Fruehauf, the chief executive for the past 12 years, will take a new role as executive chairman. LabCentral companies have raised more than $20 billion in funding and created more than 7,000 jobs in Massachusetts since its founding.

1 month ago | statnews.com | Robert Weisman

This story originally appeared in STAT’s sister publication, The Boston Globe. The deepening Trump administration budget cuts have hit Mass General Brigham, the nation’s largest hospital recipient of research grants, and other Massachusetts universities and hospitals, canceling tens of millions in funding and shutting down medical research programs in areas such as primary care, reproductive health, and pandemic preparedness.

1 month ago | bostonglobe.com | Robert Weisman |Chris Serres |Kay Lazar

The latest cuts will affect research programs awarded at least $70 million at MGB hospitals’ labs over multiple years, with most of that money already paid but at least $18 million still untapped, a federal document showed, freezing multiple research programs, some in collaboration with other labs within Harvard and at other institutions. But many of the program cuts reported by researchers haven’t yet been disclosed publicly, meaning the actual dollar loss is likely to be higher.

1 month ago | bostonglobe.com | Robert Weisman

The question looms large for millions of working Americans: Will Social Security be there when I retire? Jim Roosevelt would like to reassure people that it will. But he sees “a direct threat to the most popular government program that has ever existed” as the Trump administration cuts staff, closes offices, and has made moves, which it later reversed, making it harder to transact Social Security business by phone.

1 month ago | bostonglobe.com | Robert Weisman

Dana-Farber Cancer Institute’s plan to build a new $1.7 billion, 300-bed cancer hospital in Boston’s Longwood Medical Area won a key state approval Thursday, despite a Mass General Brigham plea to scale back the project.